Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 2, 1999, Pages 419-426

  Pendurthi, Usha R ^a   Williams, J Todd ^a   Rao, L Vijaya Mohan ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Cardioprotective effect; Endothelial cell; Monocytes; Resveratrol; Tissue factor

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; RESVERATROL; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HEART PROTECTION; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; WINE;

EID: 0032966303     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.2.419     Document Type: Article

References (54)

1. Rimm EB, Giovannucci EL, Willet WC, Colditz GA, Aschrio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338:464-468.
2. Jackson R, Scragg R, Beaglehole R. Alcohol consumption and risk of coronary heart disease. BMJ. 1991;303:211-216.
3. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med. 1992;117:646-654.
4. Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1993;339:1523-1526.
5. Renaud SC, Gueguen R, Schenker J, d'Houtaud A. Alcohol and mortality in middle-aged men from Eastern France. Epidemiology. 1998;9: 184-188.
6. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. 1993;341:1103-1104.
7. Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis. 1997;8:645-659.
8. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis implications for protection against coronary heart disease. Clin Chim Acta. 1995;235:207-219.
9. Jeandet P, Bessis R, Sbaghi M, Meunier P. Production of the phytoalexin resveratrol by grape berries as response to Botrytis attack under natural conditions. J Phytopathol. 1995;43:135-139.
10. Langcake P, Pryce RJ. The production of resveratrol and the viniferins in response to ultraviolet irradiation. Phytochemistry. 1977;16:1193-1196.
11. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol a natural product derived from grapes. Science. 1997;275:218-220.
12. Hain R, Reif H, Krause E, Langebartels R, Kindl H, Vornam B, Wiese W, Schmelzer E, Schreier PH, Stocker RH, Stenzel K. Disease resistance results from foreign phytoalexin expression in a novel plant. Nature. 1993;361:153-156.
13. Goldberg DM, Karumanchiri A, Yan J, Soleas G, Ng E, Waterhouse AL, Diamandis EP. A global survey of trans-resveratrol concentrations in commercial wines. Am J Enol Vitic. 1995;46:159-165.
14. Bertelli AAE, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, Bertelli A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tiss Reac. 1995;17:1-3.
15. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta. 1996;246:163-182.
16. Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a "prima ballerina." Thromb Haemost. 1995;74:7-17.
17. Taubman MB, Fallon JT, Schecter AD, Giesen P, Mendlowitz M, Fyfe BS, Marmur JD, Nemerson Y. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost. 1997;78:200-204.
18. Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost. 1997;78:759-764.
19. Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990;59:421-437.
20. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
21. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
22. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest. 1996; 75:451-461.
23. Bajaj SP, Rapaport SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem. 1981;11:397-412.
24. Rao LVM, Robinson T, Hoang AD. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: a kinetic study. Thromb Haemost. 1992;67:654-659.
25. Engstad CS, Gutteberg TJ, Osterud B. Modulation of blood cell activation by four commonly used anticoagulants. Thromb Haemost. 1997;77: 690-696.
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods. 1983;65:55-63.
27. Pendurthi UR, Williams JT, Rao LVM. Acidic and basic fibroblast growth factors suppress transcriptional activation of tissue factor and other inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17:940-946.
28. Pendurthi UR, Okino ST, Tukey RH. Accumulation of the nuclear dioxin (Ah) receptor and transcriptional activation of the mouse Cyp 1a-1 and Cyp 1a-2 genes. Arch Biochem Biophys. 1993;306:65-69.
29. Pendurthi UR, Williams JT, Rao LVM. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin: suppression of activation of transcription factors Egr-1, AP-1 and NF-kB. Arterioscler Thromb Vasc Biol. 1997;17:3406-3417.
30. Oeth P, Mackman N. Salicylates inhibit lipopolysaccharide-induced transcriptional activation. Blood. 1995;86:4144-4152.
31. Bertelli AAE, Giovannini L, De Caterina R, Bernini W, Migliori M, Fregoni M, Bavaresco L, Bertelli A. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res. 1996;22:61-63.
32. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A. 1997;94:14138-14143.
33. Mackman N. Regulation of the tissue factor gene. Thromb Haemost. 1997;78:747-754.
34. Parry GCN, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15:612-621.
35. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329: 1829-1834.
36. Shu I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol: the Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med. 1992;116:881-887.
37. Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien JR, Yarnell JW. Ischemic heart disease and platelet aggregation: the Caerphilly Collaborative Heart Disease Study. Circulation. 1991;83:38-44.
38. Renaud SC, Ruf JC. Effects of alcohol on platelet functions. Clin Chim Acta. 1996;246:77-89.
39. Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in the disease prevention. J Clin Lab Anal. 1997;11:287-313.
40. Goldberg DM, Hahn SE, Parkes JG. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta. 1995;237: 155-187.
41. Davies MJ. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res. 1996;82:1-32.
42. McNamara CA, Sarenbock IJ, Gimple LW, Fenton II JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91:94-98.
43. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA. 1992;89:2317-2320.
44. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem. 1995;270:4650-4660.
45. Pendurthi UR, Alok D, Rao LVM. Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: Up-regulation of poly(A) polymerase. Proc Natl Acad Sci U S A. 1997; 94:12598-12603.
46. Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol. 1998;140:1241-1253.
47. Poulsen LK, Jacobsen N, Sorensen BB, Bergenhem NCH, Kelly JD, Foster DC, Thastrup O, Ezban M, Petersen LC. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem. 1998;273:6228-6232.
48. Sato M, Suzuki Y, Okuda T, Yokotsuka K. Content of resveratrol, piceid, and their isomers in commercially available wines made from grapes cultivated in Japan. Biosci Biotechnol Biochem. 1997;61:1800-1805.
49. Goldberg DM, Ng E, Karumanchiri A, Diamandis EP, Soleas GJ. Resveratrol glucosides are important components of commercial wines. Am J Enol Vitic. 1996;47:415-420.
50. Trede NS, Tsyysykova AV, Chatila T, Goldfeld AE, Geha RS. Transcriptional activation of the human TNF-α promoter by superantigen in human monocytic cells: role of NF-κB. J Immunol. 1995;155:902-908.
51. Yao J, Mackman N, Edgington TS, Fan ST. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells: regulation by Egr-1, c-Jun and NF-κB transcription factors. J Biol Chem. 1997;272:17795-17801.
52. Bensi G, Mora M, Raugei G, Buonamassa DT, Rossini M, Melli M. An inducible enhancer controls the expression of the human interleukin 1β gene. Cell Growth Differ. 1990;1:491-497.
53. Hiscott J, Marios J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, Fenton M. Characterization of a functional NF-kappa B site in the human interleukins beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol. 1993;13: 6231-6240.
54. Brand K, Fowler BJ, Edgington TS, Mackman N. Tissue factor mRNA in THP-1 monocytic cell is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol. 1991;11:4732-4738.